臺灣結核病實作指引, published by 衛福部疾病管制署. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/omnifhir/tb/ and changes regularly. See the Directory of published versions
| Official URL: https://tb.cdc.gov.tw/tb/ValueSet/cdc-drug-sensitive-2 | Version: 0.1.0 | |||
| Active as of 2026-03-31 | Computable Name: CDCDrugSensitive2 | |||
CDC-TB檢驗通報-二線藥敏值集
References
https://tb.cdc.gov.tw/tb/CodeSystem/cdc-drug-sensitive version 📦0.1.0| Code | Display |
| S01 | 二線藥敏-高濃度Kanamycin |
| S02 | 二線藥敏-低濃度Kanamycin |
| S03 | 二線藥敏-Ofloxacin |
| S04 | 二線藥敏-Ethionamide |
| S05 | 二線藥敏-p-aminosalicylicacid |
| S06 | 二線藥敏-Rifabutin |
| S07 | 二線藥敏-Capreomycin |
| S08 | 二線藥敏-Ciprofloxacin |
| S09 | 二線藥敏-Moxifloxacin |
| S10 | 二線藥敏-Gatifloxacin |
| S11 | 二線藥敏-Levofloxacin |
| S12 | 二線藥敏-Amikacin |
| S13 | 二線藥敏-Prothionamide |
| S14 | 二線藥敏-Cycloserine |
| S15 | 二線藥敏-Terizidone |
| S16 | 二線藥敏-Thioacetazone |
| S17 | 二線藥敏-Enviomycin |
| other | 其他 |
Expansion performed internally based on codesystem CDC-TB檢驗通報-藥敏 v0.1.0 (CodeSystem)
This value set contains 18 concepts
| System | Code | Display (zh) | JSON | XML |
https://tb.cdc.gov.tw/tb/CodeSystem/cdc-drug-sensitive | S01 | |||
https://tb.cdc.gov.tw/tb/CodeSystem/cdc-drug-sensitive | S02 | |||
https://tb.cdc.gov.tw/tb/CodeSystem/cdc-drug-sensitive | S03 | |||
https://tb.cdc.gov.tw/tb/CodeSystem/cdc-drug-sensitive | S04 | |||
https://tb.cdc.gov.tw/tb/CodeSystem/cdc-drug-sensitive | S05 | |||
https://tb.cdc.gov.tw/tb/CodeSystem/cdc-drug-sensitive | S06 | |||
https://tb.cdc.gov.tw/tb/CodeSystem/cdc-drug-sensitive | S07 | |||
https://tb.cdc.gov.tw/tb/CodeSystem/cdc-drug-sensitive | S08 | |||
https://tb.cdc.gov.tw/tb/CodeSystem/cdc-drug-sensitive | S09 | |||
https://tb.cdc.gov.tw/tb/CodeSystem/cdc-drug-sensitive | S10 | |||
https://tb.cdc.gov.tw/tb/CodeSystem/cdc-drug-sensitive | S11 | |||
https://tb.cdc.gov.tw/tb/CodeSystem/cdc-drug-sensitive | S12 | |||
https://tb.cdc.gov.tw/tb/CodeSystem/cdc-drug-sensitive | S13 | |||
https://tb.cdc.gov.tw/tb/CodeSystem/cdc-drug-sensitive | S14 | |||
https://tb.cdc.gov.tw/tb/CodeSystem/cdc-drug-sensitive | S15 | |||
https://tb.cdc.gov.tw/tb/CodeSystem/cdc-drug-sensitive | S16 | |||
https://tb.cdc.gov.tw/tb/CodeSystem/cdc-drug-sensitive | S17 | |||
https://tb.cdc.gov.tw/tb/CodeSystem/cdc-drug-sensitive | other |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |